New Mesartan Tablet 40mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daehan Newpharm Co., Ltd.
MFDS item code 201507880 · Approved 2015.11.25
This product's status changed to Expired on 2025.11.25. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension
Essential hypertension is a critical condition for lowering blood pressure to normal levels, which protects vascular and cardiac health. This medication is used to effectively control blood pressure in essential hypertension to prevent cardiovascular complications.
The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have reduced effective circulating blood volume (Intravascular volume depletion) (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. No dose adjustment is necessary when this medicine is administered to elderly patients aged 65 years or older. Although no overall differences in the efficacy and safety of this medicine have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. As there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
The safety and efficacy in children have not been established.
This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so if pregnancy is confirmed, you should discontinue use immediately. It should not be used by patients who have allergies to any of the components of this medication, pregnant or breastfeeding women, patients on renal dialysis, those with severe liver impairment, patients with biliary obstruction, and individuals with certain genetic lactose intolerance. Patients who have decreased blood volume or sodium deficiency may experience hypotension, so caution is needed, and patients with impaired renal function should have their renal function and serum electrolyte levels monitored regularly. Particularly in patients with severe heart failure, renal artery stenosis, those at risk for hyperkalemia, or patients with aortic or mitral stenosis, it should be used with caution, as blood pressure can drop rapidly, and activities like driving or operating dangerous machinery should be avoided. During the use of this medication, mild side effects such as dizziness, headache, indigestion, muscle pain, and rash may occur, and rarely, angioedema or liver function abnormalities may manifest; if unusual symptoms persist, consultation with a healthcare professional is necessary. If chronic diarrhea or severe abdominal pain occurs, it may indicate a possibility of chronic malabsorption syndrome similar to intestinal diseases caused by this medication, and use should be discontinued and the doctor consulted. When taken with potassium-sparing diuretics, potassium supplements, lithium, or non-steroidal anti-inflammatory drugs (NSAIDs), the risk of side effects may increase due to interactions, so patients should inform their healthcare provider of any other medications being used. Use of this medication during pregnancy can cause severe side effects for the fetus, so if pregnancy is suspected, it should be discontinued immediately and a healthcare professional consulted. Breastfeeding women should consider that this medication may be partially transmitted through breast milk and should either discontinue breastfeeding or stop taking the medication to prevent potential adverse reactions in infants. Safety and efficacy in children have not yet been adequately established, so it should be used cautiously in pediatric patients. Elderly patients may experience increased drug concentrations, requiring caution during use. In case of overdose, hypotension or arrhythmias may occur; seek medical attention immediately if symptoms manifest. This medication has been reported to have a low risk of carcinogenicity or genotoxicity even with long-term use, but if unusual symptoms arise, it is advisable to consult an expert.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. A cool place with a storage temperature between 1 and 25 degrees Celsius is suitable.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daehan Newpharm Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.